<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Medical-Inquiry-Management on Bioecon</title><link>https://en.bioecon.ru/technologies/medical-inquiry-management/</link><description>Recent content in Medical-Inquiry-Management on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 18 Aug 2026 22:19:08 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/medical-inquiry-management/index.xml" rel="self" type="application/rss+xml"/><item><title>Medical-affairs platforms (CME, MSL)</title><link>https://en.bioecon.ru/technology/medical-affairs-platforms/</link><pubDate>Sun, 16 Aug 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/medical-affairs-platforms/</guid><description>Software platforms and CRM systems purpose-built for pharma medical-affairs teams — continuing medical education content, medical science liaison (MSL) field engagement, and medical-inquiry management — that keep scientific-exchange activity separate from and compliant alongside commercial sales.</description></item></channel></rss>